Latest Scripps Research Institute Stories
Scientists at The Scripps Research Institute (TSRI) have found a way to make dramatic improvements to the cancer cell-killing power of vinblastine, one of the most successful chemotherapy drugs of the past few decades.
A small group of immune-regulating molecules, when overproduced even moderately, can trigger the blood cancers known as lymphomas.
An international team led by scientists at The Scripps Research Institute (TSRI) has determined and analyzed the three-dimensional atomic structure of the human glucagon receptor.
New members from PwC, The Scripps Research Institute, Latham & Watkins and Thermo Fisher Scientific strengthen current board La Jolla, Calif.
An international group of scientists has shown that a drug candidate designed by scientists from the Florida campus of The Scripps Research Institute (TSRI) significantly increases exercise endurance in animal models.
- Growing in low tufty patches.